Concordia Healthcare Corp (TSE:CXR)‘s stock had its “outperform” rating restated by equities researchers at Royal Bank Of Canada in a report issued on Tuesday, reports. They currently have a C$18.50 price objective on the stock. Royal Bank Of Canada’s target price would indicate a potential upside of 206.29% from the company’s current price.

CXR has been the subject of a number of other reports. TD Securities increased their price target on Concordia Healthcare Corp from C$7.00 to C$14.00 and gave the company a “hold” rating in a research note on Monday, September 19th. Goldman Sachs Group Inc. set a C$34.00 price target on Concordia Healthcare Corp in a research note on Friday, July 22nd. Finally, CIBC cut Concordia Healthcare Corp from a “sector perform” rating to an “underperform” rating in a research note on Monday, August 15th. One analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of C$27.38.

Analyst Recommendations for Concordia Healthcare Corp (TSE:CXR)

Concordia Healthcare Corp (TSE:CXR) traded down 2.48% on Tuesday, reaching $5.89. The company’s stock had a trading volume of 97,689 shares. Concordia Healthcare Corp has a 12 month low of $5.80 and a 12 month high of $58.75. The stock’s 50 day moving average price is $8.59 and its 200 day moving average price is $24.67. The company’s market cap is $300.49 million.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at

About Concordia Healthcare Corp

Stock Target Prices

Receive News & Ratings for Concordia Healthcare Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concordia Healthcare Corp and related companies with's FREE daily email newsletter.